Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Obesity01:24

Obesity

1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

372
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
372
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

445
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

330
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
330
Bulimia Nervosa01:30

Bulimia Nervosa

1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K
Binge Eating Disorders01:23

Binge Eating Disorders

832
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
832

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

New thoughts on managing obesity.

Gut·2004
Same author

Cardiovascular risks in obesity.

Journal of endocrinological investigation·2003
Same author

A double-blind placebo-controlled clinical trial of recombinant human brain-derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy.

Journal of the peripheral nervous system : JPNS·2002
Same author

Reply: Is obesity a disease?

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2001
Same author

Dose-response issues concerning physical activity and health: an evidence-based symposium.

Medicine and science in sports and exercise·2001
Same author

Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin.

Diabetologia·2001

Video Experimental Relacionado

Updated: May 5, 2026

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

13.7K

La obesidad como problema médico.

P G Kopelman1

  • 1St Bartholomew's & The Royal London School of Medicine, Queen Mary & Westfield College, UK. P.G.Kopelman@mds.qmw.ac.uk

Nature
|April 15, 2000
PubMed
Resumen

La obesidad es una creciente crisis de salud mundial, superando a la desnutrición y las infecciones como una de las principales causas de enfermedad. Está vinculada a enfermedades graves como la diabetes, las enfermedades cardíacas y el cáncer, que requieren atención urgente.

Área de la Ciencia:

  • Salud Pública La salud pública.
  • Epidemiología La epidemiología.
  • Trastornos metabólicos Los trastornos metabólicos son trastornos metabólicos que se producen en el cuerpo.

Sus antecedentes:

  • La obesidad es un problema de salud global significativo, cada vez más frecuente en todo el mundo.
  • Se asocia con afecciones graves de salud, incluida la diabetes mellitus, la enfermedad coronaria, los cánceres y los trastornos respiratorios del sueño.
  • Las definiciones tradicionales que utilizan el índice de masa corporal (IMC) no capturan completamente los riesgos para la salud, particularmente los relacionados con la grasa intraabdominal.

Objetivo del estudio:

  • Para resaltar la creciente epidemia mundial de obesidad.
  • Subrayar las múltiples consecuencias para la salud de la obesidad más allá de las preocupaciones cosméticas.
  • Hacer hincapié en la necesidad de abordar la obesidad como una gran amenaza para la salud pública.

Más Videos Relacionados

An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Videos de Experimentos Relacionados

Last Updated: May 5, 2026

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

13.7K
An Acupoint Catgut-embedding Therapy for Treating Obesity
04:50

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

1.8K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.5K

Principales métodos:

  • Revisión de los datos epidemiológicos actuales sobre la prevalencia de la obesidad.
  • Análisis de las asociaciones establecidas entre la obesidad y las principales enfermedades no transmisibles.
  • Discusión de los factores etiológicos que contribuyen a la epidemia de obesidad.

Principales resultados:

  • La obesidad está emergiendo como una de las principales causas de morbilidad y mortalidad a nivel mundial.
  • Existe una fuerte correlación entre la obesidad y el desarrollo de enfermedades crónicas.
  • Factores como la predisposición genética, el mayor acceso a alimentos con alto contenido calórico y la reducción de la actividad física impulsan la epidemia.

Conclusiones:

  • La obesidad es una epidemia compleja con profundas implicaciones para la salud mundial.
  • Requiere un cambio de perspectiva de un problema cosmético individual a un desafío generalizado de salud pública.
  • Abordar las causas profundas de la obesidad es fundamental para mejorar el bienestar mundial.